Impact of Baseline Disease Activity and Trial Duration on Efficacy of Biologics in Active Crohn's Disease: Meta-analysis.

Brigida BarberioDavid J GracieChristopher J BlackAlexander Charles Ford

Published in: Inflammatory bowel diseases (2023)

Both the criteria used to define CD activity at study entry and the time point used to confirm efficacy may be important in maximizing therapeutic gain of active drug over placebo.

Keyphrases

disease activity
rheumatoid arthritis
systemic lupus erythematosus
systematic review
rheumatoid arthritis patients
ankylosing spondylitis
phase iii
juvenile idiopathic arthritis
study protocol
clinical trial
randomized controlled trial
emergency department